NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)
CUSIP: 64125C109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 99,963,154
- Total 13F shares
- 93,636,708
- Share change
- +347,362
- Total reported value
- $12,887,512,754
- Put/Call ratio
- 34%
- Price per share
- $137.67
- Number of holders
- 589
- Value change
- +$47,493,212
- Number of buys
- 322
- Number of sells
- 255
Quarterly Holders Quick Answers
What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 64125C109:
Top shareholders of NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
14%
|
13,760,970
|
$1,897,912,983 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.9%
|
9,930,926
|
$1,369,673,315 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4%
|
3,989,961
|
$550,295,421 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.3%
|
2,295,108
|
$316,541,376 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.3%
|
2,251,646
|
$310,547,000 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
2,065,636
|
$284,892,808 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
2.1%
|
2,055,874
|
$283,546,142 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.8%
|
1,820,796
|
$251,125,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
1,713,714
|
$236,007,250 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.4%
|
1,378,513
|
$190,122,227 | — | 31 Mar 2024 | |
| DODGE & COX |
13F
|
Company |
1.3%
|
1,265,244
|
$174,502,452 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.1%
|
1,136,942
|
$156,807,040 | — | 31 Mar 2024 | |
| DSM CAPITAL PARTNERS LLC |
13F
|
Company |
1.1%
|
1,136,002
|
$156,677,396 | — | 31 Mar 2024 | |
| BROWN ADVISORY INC |
13F
|
Company |
1.1%
|
1,088,333
|
$150,102,888 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.1%
|
1,081,449
|
$149,142,565 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.1%
|
1,054,900
|
$145,491,808 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1%
|
1,023,739
|
$141,194,083 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1%
|
1,003,750
|
$138,437,199 | — | 31 Mar 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.99%
|
994,611
|
$137,176,750 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.92%
|
921,335
|
$127,070,458 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.84%
|
841,318
|
$116,034,579 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.84%
|
837,426
|
$115,497,794 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.8%
|
804,409
|
$110,944,089 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.79%
|
793,825
|
$109,484,343 | — | 31 Mar 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.79%
|
790,193
|
$108,983,000 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.78%
|
775,727
|
$106,988,268 | — | 31 Mar 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.78%
|
775,556
|
$106,964,684 | — | 31 Mar 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.71%
|
713,525
|
$100,878,164 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.73%
|
730,209
|
$100,710,425 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
725,178
|
$100,016,550 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
715,068
|
$98,622,178 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.71%
|
712,798
|
$98,309,100 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.71%
|
710,000
|
$97,923,200 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.69%
|
691,004
|
$95,303,272 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.6%
|
599,424
|
$82,672,556 | — | 31 Mar 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.58%
|
580,617
|
$80,078,697 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.57%
|
566,713
|
$78,161,058 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.54%
|
536,500
|
$73,994,080 | — | 31 Mar 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.53%
|
527,874
|
$72,804,000 | — | 31 Mar 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.53%
|
526,582
|
$72,626,277 | — | 31 Mar 2024 | |
| Fiera Capital Corp |
13F
|
Company |
0.51%
|
511,542
|
$70,551,872 | — | 31 Mar 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.51%
|
506,666
|
$69,879,374 | — | 31 Mar 2024 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.51%
|
506,113
|
$69,803,105 | — | 31 Mar 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
0.5%
|
503,193
|
$69,400,379 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.46%
|
455,220
|
$62,783,942 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.43%
|
431,982
|
$59,578,957 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
0.43%
|
425,216
|
$58,645,791 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.42%
|
423,100
|
$58,353,952 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.42%
|
418,675
|
$57,743,656 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.41%
|
405,347
|
$55,905,458 | — | 31 Mar 2024 |
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q2 2024
As of 30 Jun 2024,
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by
589 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,636,708 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, Bellevue Group AG, GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, MORGAN STANLEY, and Dodge & Cox.
This page lists
590
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
580
Q2 2024 holders
589
Holder diff
9
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.